. P esticides are increasingly being used in agricultural production to yield larger quantities and higher quality food products. Levy (1995) reported that the volume of organophosphorus insecticides used worldwide will double in the next decade. The increased use and the increased toxicity present risks to workers applying the pesticides. Pesticide poisonings due to organophosphates exhibit the major acute signs and symptoms listed in the Table (Levy, 1995) . In assessing longer term sequelae of systemic pesticide illness, Beaumont (1995) found a slightly increased risk for mortality from heart disease. Further, chronic health effects of pesticide exposure include increased cancers, dermatitis, and effects on reproductive, nervous, and other organ systems.
The World Health Organization (WHO) estimates that a million pesticide poisonings occur annually worldwide, but the statistics documenting this occurrence are not readily available (Levy, 1995) . In the United States, only a few states, such as California and Washington, mandate reporting of pesticide illnesses; thus accurate data are not available for this country.
Agricultural workers typically have not had the benefit of occupa-ABOUT THE REVIEWER:
SECTION EDITOR:
tional health nursing services. However, beginning in 1990, the National Institute for Occupational Safety and Health (NIOSH) expanded its activities to develop a comprehensive, research based intervention program to reduce injury and disease among agricultural workers and their families (Myers, 1992 tals, clinics, and health departments in 10 states to provide surveillance of agricultural work related illness and injuries. These nurses plus other occupational health nurses who have contact with agricultural workers have a role in promoting the monitoring and surveillance of agricultural workers for toxic exposures.
The two studies reviewed by Connon in this column describe results of cholinesterase testing programs and the effects of exposure of the pesticides on the serum cholinesterase levels. Occupational health nurses can use these results to design more effective monitoring programs and insure compliance by employers. , & Schenker, M.B. (1995) . Mortality in agricultural workers after compensation claims for respiratory disease, pesticide illness and injury. Journal of Occupational and Environmental Medicine. 37(2), 160-169. Levy, B.S., & Wegman, D.H. (1995) . 
LINKING PRACT I C E
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Synopsis
The purpose of this study is to evaluate the effects of exposure to organophosphate pesticides on serum cholinesterase activity in agricultural workers, in Coatepec, Mexico. The study used a cross sectional design with repeated levels of serum cholinesterase before and after a work day. A single organophosphate pesticide was in use.
Thirty agricultural workers employed at a greenhouse near Coatepee comprised the "exposed" group. To be eligible for the study, the agricultural workers had to have been employed at the greenhouse for at least 15 days. The comparison group was selected from residents of Coatepee. The comparison group was matched to the exposed (1: 1) on age within 2 years and gender. However, because 7 of the 30 agricultural workers did not participate, the analysis was based on a total of 53 individuals (23 agricultural workers and 30 comparison participants).
Information on each study participant was collected through structured 600 interviews. Blood samples for serum cholinesterase activity were collected from the agricultural workers before and after the work day. Samples for serum cholinesterase activity were collected from the comparison group in the afternoon of the same day as the agricultural workers' samples were collected. The serum samples were analyzed using the Merck method.
An exposure classification was created by scoring and weighting certain work activities. Three levels of exposure were identified: low (the comparison group), medium (outdoor activities or indirect pesticide exposure, with the exception of fumigators), and high (activities inside the greenhouse with direct pesticide exposure, and fumigators who worked outdoors) .
Results showed that there was a statistically significant difference in mean cholinesterase level between the comparison group and the agricultural workers after the work day. In addition, for the agricultural workers, there was a statistically significant difference between mean serum cholinesterase levels before and after the work day. Furthermore, the greatest mean differences in cholinesterase levels were noted in the high exposure category, and also in the younger workers. All of the study participants had virtually no symptoms of acute pesticide poisoning, although some of the agricultural workers reported having headaches. None of the workers wore personal protective equipment (PPE) on the day of the survey.
Because of the decrease in serum cholinesterase at the end of the work day and the lack of apparent health symptoms , the authors concluded that subclinical pesticide intoxication was occurring. In addition, the authors concluded that younger workers were at greater risk for decreased serum cholinesterase levels because they tended to perform more dangerous tasks.
Critique
The conclusions of the authors suggest that agricultural workers have subclinical intoxication from exposure to organophosphate pesticides. Although the authors have provided some evidence that supports this claim, it is important to keep several points in mind when interpreting the results of this study.
For example, the study took place in one employment site and during the use of one pesticide, limiting the generalizability of these study findings to greenhouse workers who use that particular pesticide. In addition, the small sample size also limits the interpretation and the generalizability of these study findings. Furthermore , there is limited information provided about the 30 comparison participants. Were they selected from Coatepec randomly or were they a convenience sample? What was their pesticide exposure history? Are these 30 participants representative of the residents of Coatepec?
Although the workers had virtually no symptoms of acute pesticide poisoning, the decrease in cholinesterase activity between before and after the work day was 10%. However, individual variability in cholinesterase activity, apart from exposure to organophosphate pesticides , may be greater than 13% (Coye, 1986) . Furthermore, because of individual variability, the fact that the samples for the exposed and comparison groups were collected at different times of day (i.e., the exposures were before and after work, and the comparisons were in afternoon) may present a bias in that cholinesterase activity may be higher (or lower) at different times of day. However, if in fact the mean serum cholinesterase values presented in the article are by definition subclinical intoxication due to pesticides, then the authors would be correct in their conclusion that the agricultural workers in the study had subclinical intoxication due to organophosphate pesticide exposure. However, this distinction is not clearly made in the article.
The authors claim the results of this study indicate that subclinical intoxication of workers exposed to pesticides occurs every work day. However, by design, the authors surveyed the two groups on one particular day. Thus, the results obtained from this particular point in time may not reflect exposures that occur on other days of the year (including prior to this survey). Was the survey day the day of highest pesticide use, or was this work day considered "usual" in terms of job activities and pesticide application?
It would have been helpful for the authors to provide a reference for "normal range" for serum cholinesterase values by the Merck method. The particular method for serum analysis was noted in the article, and the units of measure were provided (IU-international unit is the amount of enzyme required to transform 1 umole of substrate in 1 minute). However, there is no reference to what is considered normal. Are all of the mean values reported in the study within "normal range"? Or, are the cholinesterase values for both groups indicative of depressed cholinesterase activity (which would imply that the comparison group was also experiencing cholinesterase depression)?
There is questionable evidence in the article to support the authors' claim that younger workers perform more dangerous activities. Because of the small sample size, the authors were not able to adjust for other variables that might be confounding the relationship between age and exposure. Although it,~ght appear that DECEMBER 1996. VOL. 44, NO. 12 younger workers are experiencing a greater decrease in serum cholinesterase due to their direct pesticide exposure, the findings are not conclusive that jobs with direct exposure are dangerous. The authors noted that PPE was available to workers; however, workers did not use PPE on the day of the survey.
Finally, the potential for misclassification of exposure exists. The comparison group in this study was categorized as "low," and assumes there is no direct or indirect exposure to pesticides. However, if in fact there are individuals in the sample of residents of Coatepec who have direct exposure to pesticides, then this misclassification would result in an artificially reduced association.
A CHOLINESTERASE TESTING PROGRAM FOR PESTICIDE APPLICATORS (FILLMORE, 1993)

Synopsis
The state of California has implemented guidelines for serum cholinesterase monitoring for pesticide applicators, mixerlloaders, and maintenance personnel and other employees who come in contact with Category I and II organophosphates and carbamates. The state has had a reporting requirement for pesticide exposure since 1974. However, the cholinesterase monitoring guidelines were not fully implemented until 1989. Although many studies have described worker exposures to pesticides, very few cite workers with any symptoms of toxicity.
The purpose of this retrospective cohort study was to describe the implementation of the California guidelines for pesticide reporting and to consider ways to improve on the guidelines. The data in this study were obtained from a cohort of clients of a private physician who was participating in an ongoing cholinesterase monitoring program, during the years of 1989 and 1990. The clients all had baseline cholinesterase measurements established. Blood samples for serum cholinesterase analyses were sent to a single, state certified laboratory where normal ranges for serum cholinesterase were 2,700 to 8,000 mU/mL for plasma cholinesterase, and 11,100 to 17,900 mU/mL for red blood cell cholinesterase.
In the 2 year study period, 25 companies and farms sent 155 workers for baseline cholinesterase levels. Seventy-nine (51%) of the 155 workers with baseline cholinesterase established came from 25 companies that participated in the ongoing monitoring program. Fifty-two workers who had a baseline established were employed in 13 companies that did not have an ongoing monitoring program.
The workers were asked to fill out a questionnaire with each blood sample collection. The questionnaire focused on worker symptoms,whether or not workers had seen a doctor for their symptoms, and whether they had any significant exposure event. Employees with any symptoms were given a complete physical examination.Witheach blood specimen,a form was filledout and sent to the employer. The form provided instructions to the employer about whether the employee could continue working and notified the employer of when the next cholinesterase test was recommended.
Results from this study showed that all of the 79 monitored workers were males who came from workplaces including corporate farms, family farms, and professional applicator firms. Of the 79 monitored workers, 24 were removed from duty for decreased plasma cholinesterase below 60% of baseline, according to the testing protocol outlined in the California guidelines. An additional 17 workers were removed from their jobs because of cholinesterase levels below 50% (toxic by WHO standards), but only two ofthese workers had symptoms. Interestingly, some of the non-symptomatic workers had cholinesterase levels as low as 18% of baseline.
In addition, there were no statistically significant differences between mean cholinesterase levels of the symptomatic and non-symptomatic workers who were removed from duty. Furthermore, six workers with cholinesterase activity below 60% of baseline had test values which fell within the laboratory "normal range." None of the workers were hospitalized or required treatment with atropine or 2-PAM. The authors discovered that many of the workers who had been removed from work because of exposure were subsequently laid off after returning to duty.
The relative risk of toxicity for workers for workers who had intensive pesticide exposure early in the season was high with these workers having 9.4 times greater risk than workers without the pesticide exposure. For workers who had low plasma cholinesterase baselines, their risk was 8.1 times greater. The relative risk for workers with baseline cholinesterase level less than 3,000 mU/mL was that they were 6.7 times more likely to have symptoms oftoxicity than workers whose baseline cholinesterase levels were greater than 3000 mU/mL. Five case reports were also included to provide various examples of the monitoring program.
Critique
The article describes issues related to the implementation of a cholinesterase monitoring program using the California guidelines. A single physician's records were used 602 to establish the cohort. Overall, the methods in the article were difficult to follow. For example, it was not clear from the article exactly how the cohort was defined and which individuals within the cohort were being compared. Because of this ambiguity in methods, it was difficult to follow the results reported in the article, especially regarding which denominator was being used for various comparisons.
The authors provided considerable information about the difficulties in determining baseline cholinesterase levels. Because the subsequent cholinesterase levels are compared with baseline levels, the establishment of an accurate baseline is crucial. Although individual variability may be responsible for a portion of the difference between baseline and comparison values, the possibility of laboratory error (or error in coding or reporting) also may exist. For example, six workers had symptoms and cholinesterase levels below 60% of baseline, yet their cholinesterase values were within the laboratory normal range. Other workers had no symptoms and cholinesterase levels as low as 18% of baseline. These inconsistencies might raise suspicion regarding laboratory accuracy.
The authors state that baseline cholinesterase levels that were established closer to July tended to be lower than baselines levels established at other times of the year. This may indicate that workers who had their baselines obtained in July may have had prior pesticide exposure, thus lowering their baseline value. In addition, the potential for misclassification due to inaccurate baseline may imply that the reported relative risk estimate (RR=8.1) may be artificially elevated if more non-symptomatic people were incorrectly classified in the >80% of baseline catego-ry. Furthermore, the risk estimates from this study have wide confidence intervals, probably due to small number of symptomatic or toxic workers, and should therefore be interpreted cautiously.
The authors used case studies to exemplify problems with compliance with the monitoring program (both from providers and from the workers). This was particularly helpful in understanding ways the program was failing and ways workers were creating obstacles in the program. The differences in cholinesterase baseline by month of the year also seem to support the notion of poor compliance with the monitoring program.
IMPLICATIONS FOR OCCUPATIONAL HEALTH NURSES
These articles have broad applicability to occupational health nursing, particularly in the area of worker surveillance programs involving biological monitoring. Although both of these articles are oriented toward cholinesterase monitoring for pesticide exposure, issues explored in the critique have implications for biomonitoring programs and for occupational health nurses who conduct research with employee groups.
One point that both of these articles have in common is the need for repeated measures in interpreting biological markers. As was gleaned from the Fillmore article, biological monitoring programs are far more complicated than measuring a few laboratory values. Attention must be paid to the methods for specimen collection, data collection, laboratory validity and reliability, and in determining a baseline (or normal range) for comparison of future samples. In addition, careful attention must be given to the determination of the level of change necessary to be considered "important" enough to war-rant action (such as worker removal from exposure).
In both of the articles, the cholinesterase monitoring was viewed as a type of "sentinel" event, or early warning system to identify workers exposed (or over exposed) to pesticides. The advantage of biomonitoring is that workers at risk can be identified earlier in the disease process. However, with this method of early detection, potential ethical issues need to be considered including confidentiality, notification, providing timely advice to employers, and the potential effects of removal from work or limited duty placement.
Issues raised from the Carillo study include adequate sample size, study design issues, exposure classi-fication schemes, and interpretation of laboratory values and of data analyses. For occupational health nurses interested in conducting workplace studies, adequate numbers of study participants are essential for data analysis and interpretation. As illustrated in this article, determining serum cholinesterase levels may represent occupational and non-occupational exposures, which places even more importance on accurate classification of exposure.
Occupational health nurses play an important role in collecting information on workplace exposures, workers at risk, and human responses to those exposures. They are in a key position for evaluating worksite monitoring programs and for con-ducting research aimed toward promoting worker health and safety.
